| P2093 | author name string | Ronald G Victor | |
| P2860 | cites work | Familial dysautonomia is caused by mutations of the IKAP gene | Q24536229 |
| | The ion channel ASIC2 is required for baroreceptor and autonomic control of the circulation. | Q28507500 |
| | Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature | Q30425679 |
| | The sympathetic control of blood pressure | Q30440682 |
| | Gadolinium inhibits mechanoelectrical transduction in rabbit carotid baroreceptors. Implication of stretch-activated channels. | Q30533611 |
| | Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network | Q33789175 |
| | The immune system in hypertension | Q33957722 |
| | Blood pressure control--special role of the kidneys and body fluids | Q34126033 |
| | Episodic dopamine discharge in paroxysmal hypertension. Page's syndrome revisited | Q34188409 |
| | Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial | Q34254971 |
| | Arterial baroreflexes in renal hypertensive rabbits. Selectivity and redundancy of baroreceptor influence on heart rate, vascular resistance, and lumbar sympathetic nerve activity. | Q34272593 |
| | Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial | Q34281203 |
| | Cellular mechanisms of baroreceptor integration at the nucleus tractus solitarius | Q34310901 |
| | 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34351265 |
| | Afferent baroreflex failure in familial dysautonomia | Q34370035 |
| | Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study | Q34543021 |
| | New aspects of blood pressure regulation | Q75825080 |
| | Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure | Q77371202 |
| | Cardiovascular effects of direct stimulation of the carotid sinus nerve in man | Q78457678 |
| | The carotid sinus. Clinical value of its stimulation | Q79062844 |
| | Effect of spironolactone on blood pressure in subjects with resistant hypertension | Q79798622 |
| | Results of treatment of patients with hypertension by total thoracic and partial to total lumbar sympathectomy, splanchnicectomy and celiac ganglionectomy | Q80345445 |
| | Sympathetic neural mechanisms in human hypertension | Q81917641 |
| | Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction | Q83149957 |
| | Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: results from European and United States trials of the Rheos system | Q83927039 |
| | Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension | Q84264441 |
| | Missed opportunities for treatment of uncontrolled hypertension at physician office visits in the United States, 2005 through 2009 | Q84743268 |
| | Ethnicity and sympathetic tone: predictors of the blood pressure response to renal denervation? | Q85651264 |
| | Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation | Q86001835 |
| | Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension | Q86601730 |
| | Baroreflex activation therapy in patients with pre-existing implantable cardioverter-defibrillator: compatible, complementary therapies | Q87288147 |
| | Limited acute influences of electrical baroreceptor activation on insulin sensitivity and glucose delivery: a randomized, double-blind, crossover clinical study | Q87475927 |
| | Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel | Q88140702 |
| | Improved blood pressure control associated with a large-scale hypertension program | Q34730228 |
| | Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research | Q34768060 |
| | Salt and blood pressure: new insight from human genetic studies | Q35176915 |
| | Involvement of IKAP in peripheral target innervation and in specific JNK and NGF signaling in developing PNS neurons | Q35436000 |
| | Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008 | Q35533435 |
| | Rostral ventrolateral medulla C1 neurons and cardiovascular regulation | Q35545565 |
| | Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes | Q35574979 |
| | Physiology in perspective: The Wisdom of the Body. Neural control of the kidney | Q36232564 |
| | Pheochromocytoma - update on disease management | Q36328071 |
| | Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. | Q36412644 |
| | Arterial baroreceptor input contributes to long-term control of blood pressure | Q36674353 |
| | Paroxysmal hypertension: the role of stress and psychological factors | Q37209326 |
| | Lateralization of expression of neural sympathetic activity to the vessels and effects of carotid baroreceptor stimulation | Q37276213 |
| | Physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010. | Q37595772 |
| | Carotid baroreflex activation: past, present, and future | Q37738031 |
| | Premise, promise, and potential limitations of invasive devices to treat hypertension | Q37815451 |
| | Central sympatholytic drugs | Q37928130 |
| | Renal sympathetic denervation: applications in hypertension and beyond. | Q38115114 |
| | The autonomic nervous system and hypertension | Q38214075 |
| | Resistant hypertension: a review of diagnosis and management. | Q38217294 |
| | Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction | Q38266330 |
| | Renal denervation for treatment of drug-resistant hypertension | Q38281699 |
| | Bilateral or unilateral stimulation for baroreflex activation therapy | Q38421944 |
| | Role of the Baroreceptor Reflex in Daily Control of Arterial Blood Pressure and Other Variables in Dogs | Q39325078 |
| | Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves | Q39594598 |
| | Baroreceptor reflexes in human hypertension | Q39606219 |
| | Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial | Q39721026 |
| | Receptors under pressure. An update on baroreceptors | Q40280129 |
| | Prostaglandins contribute to activation of baroreceptors in rabbits. Possible paracrine influence of endothelium | Q41211566 |
| | Circulatory reflexes from carotid and extracarotid baroreceptor areas in man | Q41292184 |
| | The brain and hypertension: reflections on 35 years of inquiry into the neurobiology of the circulation | Q41414339 |
| | Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension | Q41756409 |
| | Baroreflex activation therapy for the treatment of drug-resistant hypertension: new developments | Q42217482 |
| | Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. | Q43184350 |
| | Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study | Q43473084 |
| | Interventional cardiology: Indications for renal denervation: a balanced approach? | Q43819086 |
| | Unloading arterial baroreceptors causes neurogenic hypertension | Q43917412 |
| | Impact of baroreflex activation therapy on renal function--a pilot study | Q44076436 |
| | Hypertension: Further EnligHTNment on renal sympathetic denervation | Q44140367 |
| | Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation | Q44650536 |
| | ??? | Q94616795 |
| | Prolonged activation of the baroreflex produces sustained hypotension. | Q44715083 |
| | Effects of cocaine on heart rate variability in healthy subjects | Q44753602 |
| | Transmission of arterial baroreflex signals depends on neuronal nitric oxide synthase | Q44774839 |
| | Effects of chronic baroreceptor unloading on blood pressure in the dog. | Q45162625 |
| | Unexplained symptomatic paroxysmal hypertension in pseudopheochromocytoma: a stress response disorder? | Q46176964 |
| | Neuronal prostacyclin is an autocrine regulator of arterial baroreceptor activity | Q46630192 |
| | Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons | Q47992031 |
| | Sympathetic nervous system moves toward center stage in cardiovascular medicine: from Thomas Willis to resistant hypertension | Q48097729 |
| | Hemodynamic effects elicited by stimulation of the nucleus tractus solitarii | Q48226195 |
| | Vesicular glutamate transporters and neuronal nitric oxide synthase colocalize in aortic depressor afferent neurons | Q48517058 |
| | Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery | Q48600112 |
| | Release of glutamate in the nucleus tractus solitarii in response to baroreflex activation in rats | Q48933556 |
| | Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings. | Q50699150 |
| | Management of uncontrollable hypertension with a carotid sinus stimulation device. | Q50904991 |
| | An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. | Q51083409 |
| | Effects of unilateral and bilateral carotid baroreflex stimulation on cardiac and neural sympathetic discharge oscillatory patterns. | Q51660466 |
| | Baroreflex failure. | Q52939077 |
| | Relative contributions of cardiopulmonary and sinoaortic baroreflexes in causing sympathetic activation in the human skeletal muscle circulation during orthostatic stress. | Q54234633 |
| | Reflex sympathetic activation induces acute insulin resistance in the human forearm. | Q54240946 |
| | Sympathetic overactivity in patients with chronic renal failure | Q54249718 |
| | The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N(omega)-nitro-L-arginine methyl ester. | Q54329429 |
| | Baropacing of the carotid sinus nerve for treatment of "Intractable" hypertension | Q54627324 |
| | Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg | Q56419300 |
| | Episodic Dopamine Discharge in Paroxysmal Hypertension | Q56595254 |
| | Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age | Q67267135 |
| | Arterial baroreflex control of sympathetic nerve activity during elevation of blood pressure in normal man: dominance of aortic baroreflexes | Q68255952 |
| | "Steady-state" properties of the baroreceptor-heart rate reflex in essential hypertension in man | Q68364281 |
| | Diminished baroreflex sensitivity in high blood pressure | Q68587239 |
| | Cardiovascular and respiratory changes during sleep in normal and hypertensive subjects | Q68603261 |
| | Defective cardiac parasympathetic control in patients with heart disease | Q68757337 |
| | Functional asymmetry in carotid sinus cardiac reflexes in humans | Q68852764 |
| | Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans | Q69751566 |
| | Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg | Q69827758 |
| | Importance of aortic baroreflex in regulation of sympathetic responses during hypotension. Evidence from direct sympathetic nerve recordings in humans | Q69936140 |
| | Bilateral carotid sinus nerve stimulation in the treatment of hypertension | Q70393248 |
| | Electrical Stimulation of the Carotid Sinus Nerve | Q72350703 |
| | Braunwald NS: Treatment of paroxysmal supraventricular trachycardia by electrical stimulation of the carotid-sinus nerves | Q72492425 |
| | Summation of bilateral carotid sinus signals in the barostatic reflex | Q72603922 |
| | Both NMDA and non-NMDA receptors in the NTS participate in the baroreceptor reflex in rats | Q72762388 |
| | Surgical treatment of hypertension with reference to baropacing | Q72842096 |
| | Moxonidine improves insulin sensitivity in insulin-resistant hypertensives | Q72996614 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 451-463 | |
| P577 | publication date | 2015-07-07 | |
| P1433 | published in | Nature Reviews Cardiology | Q2108444 |
| P1476 | title | Carotid baroreflex activation therapy for resistant hypertension | |
| P478 | volume | 12 | |